Amphastar Pharmaceuticals, Inc.
AMPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001297184
In the last 90 days, Amphastar Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 212 institutions reported holding it in 13F filings for Q2 2026, worth $572.1M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Amphastar Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 168 | 1 | 203 | +36 |
| Shares | 29.2M | 26 | 29.8M | +671.0K (+2.3%) |
| Value | $678.8M | $1.00K | $1.07B | +$392.5M (+57.8%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (55)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (19)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Alberta Investment Management Corp | 52,164 | $1.22M |
| State of New Jersey Common Pension Fund D | 38,958 | $907.0K |
| Walleye Capital LLC | 30,267 | $705.0K |
| State Board of Administration of Florida Retirement System | 24,130 | $562.0K |
| Engineers Gate Manager LP | 18,094 | $421.0K |
| Campbell & CO Investment Adviser LLC | 14,800 | $345.0K |
| Norges Bank | 11,600 | $270.0K |
| Diversified Trust Co | 11,018 | $257.0K |
| MQS Management LLC | 10,935 | $255.0K |
| Factorial Partners, LLC | 10,900 | $254.0K |
| Denali Advisors LLC | 5,700 | $133.0K |
| Eaton Vance Management | 2,034 | $48.0K |
| Signet Financial Management, LLC | 1,926 | $45.0K |
| First Quadrant L P | 1,562 | $36.0K |
| Total Clarity Wealth Management, Inc. | 325 | $8.00K |
| McDonald Partners LLC | 66 | $1.54K |
| Absolute Capital Management, LLC | 66 | $1.54K |
| Sageworth Trust Co | 48 | $1.00K |
| Rockefeller Capital Management L.P. | 9 | $0 |
Not filed for Q1 2022 yet (1)
Institutions that held Amphastar Pharmaceuticals, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| NEXT Financial Group, Inc | 26 | $1.00K |